SCHEMBL19797154

SCHEMBL19797154

C=C(C)C(=O)OCCc1cc(-c2ccc(CCCCC)cc2)ccc1-c1ccc2cc(OCCO)c(COC(=O)C(=C)C)cc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 11/20 0.34
MEN1 O00255 2/20 0.34
ALDH1A1 P00352 2/20 0.34
KMT2A Q03164 2/20 0.34
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
CYP3A4 P08684 1/20 0.34
MAPK1 P28482 1/20 0.34
CASP1 P29466 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SLCO1B3 Q9NPD5 1/20 0.34
SLCO1B1 Q9Y6L6 1/20 0.34
THRB P10828 2/20 0.33
THRA P10827 1/20 0.33
RARA P10276 3/20 0.33
RARG P13631 2/20 0.33
PTPN1 P18031 1/20 0.33
PTPN6 P29350 1/20 0.33
PTPN11 Q06124 1/20 0.33
TSHR P16473 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19797155 0.92 PTPN11 (0.34) RARBMEN1ALDH1A1KMT2AUSP2
SCHEMBL19797152 0.88 MEN1 (0.37) RARBMEN1ALDH1A1KMT2AUSP2
SCHEMBL19804602 0.88 EGFR (0.35) RARBRARARARG
SCHEMBL17070363 0.87 CNR2 (0.39) RARBMEN1KMT2AMAPK1SMN1; SMN2
SCHEMBL19796616 0.86 RARB (0.39) RARBMEN1ALDH1A1KMT2AUSP2
SCHEMBL19624536 0.86 MAPK1 (0.39) RARBMEN1ALDH1A1KMT2AUSP2
SCHEMBL19624679 0.85 HTT (0.38) RARBMEN1ALDH1A1KMT2AUSP2
SCHEMBL31746991 0.85 RARB (0.39) RARBMEN1KMT2AMAPK1SMN1; SMN2
SCHEMBL17063573 0.85 RARB (0.39) RARBMEN1KMT2AMAPK1SMN1; SMN2
SCHEMBL19797148 0.84 THRB (0.39) RARBMEN1ALDH1A1KMT2AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 RARB 3517/4885MEN1 1151/4885ALDH1A1 2472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.